Patents by Inventor Yong Mi

Yong Mi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060139060
    Abstract: A semiconductor memory device is capable of adjusting effective data period of data. The semiconductor memory device includes a buffering unit for buffering input data, a window adjusting unit, and a transmitting unit. The window adjusting unit is for adjusting a window of the buffered data outputted from the buffering unit in response to plural metal option. The window adjusting unit includes a first driving unit for driving an output node in response to the output signal from the buffering unit and a second driving unit for additionally driving the output node in response to the output signal from the buffering unit. Meanwhile, the transmitting unit delivers output of the window adjusting unit into a core block.
    Type: Application
    Filed: May 6, 2005
    Publication date: June 29, 2006
    Inventor: Yong-Mi Kim
  • Publication number: 20060140275
    Abstract: A motion-vector operation device includes an upper memory composed of first and second banks that store motion vectors of a lower block group belonging to a macroblock, a left memory storing motion vectors of a right block group belonging to a macroblock, and an estimator predicting a motion vector of a current block with reference to the motion vectors stored in the first and second banks of the upper memory and the left memory in accordance with an operation mode and a position of the current block in a super macroblock.
    Type: Application
    Filed: September 7, 2005
    Publication date: June 29, 2006
    Inventors: Yong-Mi Lee, Deuk-Soo Jung, Chang-Young Jung, Jung-Sun Kang
  • Publication number: 20060133504
    Abstract: A deblocking filter includes a current macroblock buffer memory configured to store video data of a current macroblock to be filtered, a side macroblock buffer memory configured to store a portion of video data of neighboring macroblocks located on the side of the current macroblock, a register buffer array configured to store video data read from the current macroblock buffer memory for current filtering, video data read from the side macroblock buffer memory, and data of neighboring macroblocks, and an edge filter that is connected to the register buffer array and is configured to perform horizontal or vertical filtering on an edge of a subblock of the current macroblock of video data and to perform the other of horizontal or vertical filtering on an edge of a subsequent subblock of the current macroblock of the video data, simultaneously. Vertical filtering uses the data from the neighboring macroblocks and horizontal filtering uses the video data from the side macroblock buffer memory.
    Type: Application
    Filed: December 14, 2005
    Publication date: June 22, 2006
    Inventors: Deuk-soo Jung, Chang-young Jung, Yong-mi Lee, Jung-sun Kang
  • Publication number: 20060091901
    Abstract: An on-die termination circuit with a stable effective termination resistance value and stabilized impedance mismatching. The on-die termination circuit includes: a decoding unit for decoding set values of an extended mode register set; an ODT output driver block including a plurality of output driver units connected in parallel with an output node for outputting an output signal and assigned with different resistance values; and a control signal generation block for generating a plurality of pull up and pull down control signals for turning on/off the plurality of output driver units in response to output signals of the decoding unit.
    Type: Application
    Filed: March 1, 2005
    Publication date: May 4, 2006
    Inventor: Yong-Mi Kim
  • Patent number: 7027351
    Abstract: Provided is directed to a negative word line driver, including: a block select address generation unit for generating first and second block select addresses having a block information according to an active signal; a row decoder controller for generating a control signal to disable a word line; a main word line driver for accessing a main word line by being driven in response to a signal coding the first block select address and the control signal; and a phi X driver for accessing a sub word line by being driven in response to a signal coding the second block select address and the control signal wloff.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: April 11, 2006
    Assignee: Hynix Semiconductor Inc.
    Inventors: Kang Seol Lee, Yong Mi Kim
  • Patent number: 6996023
    Abstract: There is provided a semiconductor memory device which is capable of reducing a current consumption in an active mode. The semiconductor memory device includes an internal voltage supply block and an internal voltage control block. The internal voltage supplying block is enabled in response to an internal voltage driving enable signal and generates an internal voltage used in an internal operation of the semiconductor memory device. The internal voltage control block activates the internal voltage driving enable signal during a predetermined period after the semiconductor memory device enters an active operation period and during a period corresponding to read/write operations.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: February 7, 2006
    Assignee: Hynix Semiconductor Inc.
    Inventor: Yong-Mi Kim
  • Publication number: 20050270073
    Abstract: In a clock switching apparatus, a corresponding mask clock signal is generated for at least one of first and second clock signals. A mask clock signal has an interval of a predetermined logical level near the switching between the clock signals. Each mask clock signal is synchronized to the first and/or second clock signals. Such an interval in the mask clock signal prevents occurrence of glitches in an output clock signal that is switched between at least one mask clock signal and/or at least one clock signal.
    Type: Application
    Filed: April 19, 2005
    Publication date: December 8, 2005
    Inventors: Yong-mi Lee, Hae-Jin Song
  • Patent number: 6868701
    Abstract: Disclosed is an improved washing machine equipped with means for generating microbubbles of air in the detergent-containing water circulated from and to the stationary outer tub of the washing machine.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: March 22, 2005
    Inventor: Yong Mi Lee
  • Publication number: 20050024911
    Abstract: There is provided a semiconductor memory device which is capable of reducing a current consumption in an active mode. The semiconductor memory device includes an internal voltage supply block and an internal voltage control block. The internal voltage supplying block is enabled in response to an internal voltage driving enable signal and generates an internal voltage used in an internal operation of the semiconductor memory device. The internal voltage control block activates the internal voltage driving enable signal during a predetermined period after the semiconductor memory device enters an active operation period and during a period corresponding to read/write operations.
    Type: Application
    Filed: December 22, 2003
    Publication date: February 3, 2005
    Inventor: Yong-Mi Kim
  • Publication number: 20040151149
    Abstract: There is provided a media access controller with a power-save mode. Particularly, the media access controller of the present invention minimizes power loss by disabling clocks applied to all blocks, including CPU, of the media access controller during the power-save mode. The media access controller of the present invention includes: a power-save master for securing stable transmission/reception of data through bus by respective processors contained in the controller; a wake-up timer for noticing that the power-save mode is expired; a power control unit for determining whether to supply a power to a phase-locked loop, and a timing when clocks for the media access controller are applied and disabled; and a locktime register for storing a locktime when an output of the phase-locked loop is settled. Additionally, there is provided a method of efficiently changing the media access controller from the active mode to the power-save mode, and vice versa.
    Type: Application
    Filed: January 14, 2004
    Publication date: August 5, 2004
    Applicant: Samsung Electronics Co., Ltd.
    Inventors: Hae-Jin Song, Kab-Jo Lee, Yong-Mi Lee
  • Publication number: 20040102450
    Abstract: This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa..
    Type: Application
    Filed: July 25, 2003
    Publication date: May 27, 2004
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: William R. Ewing, Michael R. Becker, Yong Mi Choi-Sledeski, Heinz W. Pauls, Wei He, Stephen M. Condon, Roderick S. Davis, Barbara A. Hanney, Alfred P. Spada, Christopher J. Burns, John Z. Jiang, Aiwen Li, Michael R. Myers, Wan F. Lau, Gregory B. Poli, Mark A. Bobko, Robert L. Morris, Joseph M. Karpinski, Timothy F. Gallagher, Kent W. Neuenschwander, Robert D. Groneberg, Jean-Francois Sabuco
  • Publication number: 20030230122
    Abstract: Disclosed is an improved washing machine equipped with means for generating microbubbles of air in the detergent-containing water circulated from and to the stationary outer tub of the washing machine.
    Type: Application
    Filed: June 14, 2002
    Publication date: December 18, 2003
    Inventor: Yong Mi Lee
  • Publication number: 20030176390
    Abstract: This invention is directed to methods of treating insulin resistance syndrome and diabetes in a patient in need thereof, comprising administering to said patient a pharmaceutically effective amount of a compound derived from adenosine and analogues thereof, or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable prodrug thereof, an N-oxide thereof, a hydrate thereof or a solvate thereof, or a pharmaceutical composition comprising such compound.
    Type: Application
    Filed: May 14, 2002
    Publication date: September 18, 2003
    Inventors: Andreas Herling, Gerhard Jaehne, Martin P. Maguire, Alfred P. Spada, Michael R. Myers, Yong Mi Choi-Sledeski, Heinz W. Pauls, William R. Ewing
  • Patent number: 6602864
    Abstract: The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
    Type: Grant
    Filed: June 3, 1998
    Date of Patent: August 5, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Yong Mi Choi-Sledeski, Henry W. Pauls, Jeffrey N. Barton, William R. Ewing, Daniel M. Green, Michael R. Becker, Yong Gong
  • Patent number: 6559313
    Abstract: This invention is directed to intermediates of the formula wherein Z is 4-trifluoromethylpyridin-2-yl or 5-trifluoromethylpyridin-2-yl which are useful in the preparation of compounds useful as antihypertensive, anti-ischemic, cardioprotective, and antilipolytic agents.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: May 6, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Michael R. Myers, Martin P. Maguire, Alfred P. Spada, William R. Ewing, Henry W. Pauls, Yong Mi Choi-Sledeski
  • Publication number: 20020099030
    Abstract: This invention relates to adenosine derivatives and analogues which possess biological activity and are useful as anti-hypertensive, cardioprotective, anti-ischemic, and antilipolytic agents, to pharmaceutical compositions including such compounds, and to their use in treating hypertension, myocardial ischemia, ameliorating ischemic injury and myocardial infarct size consequent to myocardial ischemia, and treating hyperlipidemia and hypercholesterolemia, and to methods and intermediates used in the preparation of such compounds.
    Type: Application
    Filed: March 22, 2002
    Publication date: July 25, 2002
    Inventors: Michael R. Myers, Martin P. Maguire, Alfred P. Spada, William R Ewing, Henry W. Pauls, Yong Mi Choi-Sledeski
  • Patent number: 6376472
    Abstract: A compound of the formula wherein K is N; Q is CH2 or O; R6 is hydrogen, alkyl, allyl, 2-methylallyl, 2-butenyl, or cycloalkyl where the nitrogen of the ring of X is substituted by Y; E is O or S; Y is hydrogen, alkyl, aralkyl, substituted aralkyl, aryl, substituted aryl, heterocyclyl, substituted heterocyclyl, heterocyclylalkyl, or substituted heterocyclylalkyl; and n and p are independently 0, 1, 2, or 3, provided that n+p is at least 1; T is hydrogen, alkyl, alkylcarbonyl, alkylthiocarbonyl, halo, carboxyl, A and B are independently hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, or OR′; or a pharmaceutically acceptable salt thereof, a pharmaceutic-ally acceptable prodrug thereof, an N-oxide thereof, a hydrate thereof or a solvate thereof.
    Type: Grant
    Filed: October 16, 1998
    Date of Patent: April 23, 2002
    Assignee: Aventis Pharmaceuticals, Inc.
    Inventors: Michael R. Myers, Martin P. Maguire, Alfred P. Spada, William R. Ewing, Henry W. Pauls, Yong Mi Choi-Sledeski
  • Publication number: 20020013310
    Abstract: The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, for treating a patient suffering from, or subject to, a physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
    Type: Application
    Filed: July 30, 2001
    Publication date: January 31, 2002
    Inventors: Yong Mi Choi-Sledeski, Heinz W. Pauls, Jeffrey N. Barton, William R. Ewing, Daniel M. Green, Michael R. Becker, Yong Gong, Julian Levell
  • Patent number: 6281227
    Abstract: The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, for treating a patient suffering from, or subject to, a physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
    Type: Grant
    Filed: December 2, 1999
    Date of Patent: August 28, 2001
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Yong Mi Choi-Sledeski, Heinz W. Pauls, Jeffrey N. Barton, William R. Ewing, Daniel M. Green, Michael R. Becker, Yong Gong, Julian Levell
  • Patent number: 6034093
    Abstract: The compounds of formula I exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
    Type: Grant
    Filed: August 6, 1998
    Date of Patent: March 7, 2000
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.
    Inventors: William R. Ewing, Michael R. Becker, Yong Mi Choi-Sledeski, Heinz W. Pauls, Daniel G. McGarry, Roderick S. Davis, Alfred P. Spada